The burden of antenatal heart disease in South Africa: A systematic review

listen audio

Study Justification:
– Maternal mortality in South Africa is rising, and heart conditions currently account for 41% of indirect causes of deaths.
– Little is known about the burden of heart disease in pregnant South Africans.
Study Highlights:
– The prevalence of heart disease in pregnant South Africans ranged from 123 to 943 per 100,000 deliveries, with a median prevalence of 616 per 100,000.
– Rheumatic valvular lesions were the most common abnormalities, but cardiomyopathies were disproportionately high compared to other developing countries.
– Peripartum case-fatality rates were as high as 9.5% in areas with limited access to care.
– The most frequent complications were pulmonary edema, thromboembolism, and major bleeding with warfarin use.
– Perinatal mortality ranged from 8.9% to 23.8%, and mitral lesions were associated with low birth weight.
Study Recommendations:
– Standard reporting criteria should be implemented for future reports on antenatal heart disease in South Africa.
– Further research is needed to better understand the epidemiology and outcomes of heart disease in pregnant South Africans.
– Improved access to care and management strategies are necessary to reduce maternal and perinatal morbidity and mortality.
Key Role Players:
– Researchers and scientists specializing in cardiology and maternal health
– Healthcare providers, including obstetricians, cardiologists, and nurses
– Policy makers and government officials responsible for healthcare planning and funding
– Non-governmental organizations (NGOs) focused on maternal and child health
Cost Items for Planning Recommendations:
– Research funding for conducting further studies and collecting data on antenatal heart disease in South Africa
– Training and education programs for healthcare providers to improve their knowledge and skills in managing heart disease in pregnant women
– Development and implementation of standardized reporting criteria for future studies
– Investment in healthcare infrastructure and resources to improve access to care for pregnant women with heart disease
– Public awareness campaigns to educate pregnant women and their families about the risks and management of heart disease during pregnancy

The strength of evidence for this abstract is 7 out of 10.
The evidence in the abstract is moderately strong. The systematic review included seven studies and provided epidemiological data on antenatal heart disease in South African women. The prevalence of heart disease, peripartum outcomes, and complications were reported. However, the abstract mentions that meta-analysis could not be performed due to heterogeneity of the included studies, which may limit the strength of the evidence. To improve the evidence, future studies could aim for more standardized reporting criteria and consider addressing the heterogeneity in study design and population.

Background: Maternal mortality in South Africa is rising, and heart conditions currently account for 41 per cent of indirect causes of deaths. Little is known about the burden of heart disease in pregnant South Africans.Methods: We systematically reviewed the contemporary epidemiology and peripartum outcomes of heart disease in South African women attending antenatal care. Searches were performed in PubMed, ISI Web of Science, the EBSCO Africa-Wide database, the South African Union Catalogue, and the Current and Completed Research database (South Africa). References of included articles were also hand-searched. Studies reporting epidemiologic data on antenatal heart disease in South Africa were included. Data on morbidity and mortality were also collected.Results: Seven studies were included in the systematic review. The prevalence of heart disease ranged from 123 to 943 per 100,000 deliveries, with a median prevalence of 616 per 100,000. Rheumatic valvular lesions were the commonest abnormalities, although cardiomyopathies were disproportionately high in comparison with other developing countries. Peripartum case-fatality rates were as high as 9.5 per cent in areas with limited access to care. The most frequent complications were pulmonary oedema, thromboembolism, and major bleeding with warfarin use. Perinatal mortality ranged from 8.9 to 23.8 per cent, whilst mitral lesions were associated with low birth weight. Meta-analysis could not be performed due to clinical and statistical heterogeneity of the included studies.Conclusion: Approximately 0.6 per cent of pregnant South Africans have pre-existing cardiac abnormalities, with rheumatic lesions being the commonest. Maternal and perinatal morbidity and mortality continue to be very high. We conclude this review by summarising limitations of the current literature and recommending standard reporting criteria for future reports. © 2012 Watkins et al; licensee BioMed Central Ltd.

Any study investigating antenatal heart diseases in pregnant South African women was considered for review. In order to obtain the best epidemiological data, only studies that were designed to measure hospital- or community-based burden of heart disease were included in the final analysis. Studies were excluded if they did not provide any information regarding a reference population of pregnant women without heart disease. The review was limited to studies conducted in participants over 18 years of age. Although we secondarily collected data on maternal and foetal outcomes, studies were not included or excluded on this basis. Language of publication was restricted to English articles only. Editorials and review articles were excluded. Two independent reviewers (DAW and MS) reviewed lists of articles obtained from several databases relevant to the South African population. The pre-specified search strategy for each database was as follows: MEDLINE was searched with the term “Heart Diseases”[MeSH] AND pregnan*[TIAB] AND “South Africa”[All Fields]; ISI Web of Science was searched with the term TS = HEART DISEASE (and) TS = PREGNAN* (and) CU = SOUTH AFRICA; and the EBSCO Africa-Wide database was searched with the term SU = heart or cardiac or cardiovascular (and) TI = disease* (and) SU = pregnan* (and) TX = South Africa. To search for South African conference proceedings, theses, and abstracts, two internal databases at the University of Cape Town Health Sciences Library were searched. Current and Completed Research (South Africa) [8] was searched using “heart AND pregnancy” and the South African Union Catalogue (SACat) section on South African Theses [8] was searched using the term (“heart” OR “cardiac”) AND “pregnancy.” All databases were accessed during the month of March 2011. Articles were selected on the basis of relevant title with relevant abstract and full text articles were obtained from potentially eligible reports. In the final stage of the search, reference lists of full-text articles were hand-searched. Discrepancies were resolved by consensus discussion between the two reviewers with adjudication by the senior author (BMM) as necessary. Two reviewers (DAW and MS) used a standardised data extraction form to obtain information on study design, patient demographics, and total numbers of each cardiac lesion. Secondarily, basic information was obtained on the rates of specific outcomes: maternal death, pulmonary oedema, thrombosis, haemorrhage, and foetal demise. Again, discrepancies were adjudicated by consensus discussion between the two reviewers with the assistance of the senior author (BMM) as necessary. When study data were incomplete or contradictory with regard to the primary objective, the original author of the manuscript was contacted to clarify his or her findings. Prevalences, case-fatality rates, and when applicable, perinatal mortality rates, are expressed per standard 100,000 deliveries. In hospital-based series and cohorts, we have reported the “prevalence” of antenatal heart disease as the number of patients in the study (all with heart disease) divided by the total number of deliveries at the institution, multiplied by 100,000. In some reports, cases of heart disease were reported in terms of “incidence”; however as most of the cardiac lesions likely predated pregnancy, we felt this term to be imprecise. We have also reported death rates as case-fatality in spite of the fact that papers tended to use the term “maternal mortality” because in our assessment, deaths were almost exclusively due to complications of the cardiac lesion (e.g., pulmonary oedema or coagulopathies related to warfarin misuse). We report “perinatal mortality” as any stillbirth, peripartum or neonatal death (i.e., less than 1 month). Unfortunately some studies did not have full records for all patients [9,10] and thus, we analysed perinatal deaths in a subset of women with cardiac disease, likely inflating mortality rates. We intended to perform a meta-analysis in an attempt to provide an aggregate of the prevalence data from the included studies. All reported numerical data were stored and analysed using Microsoft Excel 2010.

N/A

Based on the provided information, here are some potential innovations that could be used to improve access to maternal health:

1. Telemedicine: Implementing telemedicine programs that allow pregnant women with heart disease to remotely consult with healthcare professionals. This can help overcome geographical barriers and provide access to specialized care.

2. Mobile health (mHealth) applications: Developing mobile applications that provide educational resources, reminders for medication and appointments, and allow women to track their symptoms and vital signs. This can empower pregnant women with heart disease to actively manage their condition and seek timely medical attention.

3. Community health workers: Training and deploying community health workers who can provide education, support, and basic healthcare services to pregnant women with heart disease in underserved areas. These workers can act as a bridge between the community and healthcare facilities, ensuring that women receive appropriate care and follow-up.

4. Improved referral systems: Establishing efficient referral systems between primary healthcare centers and specialized cardiac care centers. This can ensure timely and appropriate management of pregnant women with heart disease, reducing complications and improving outcomes.

5. Collaborative care models: Implementing collaborative care models that involve multidisciplinary teams, including obstetricians, cardiologists, nurses, and social workers. This approach can facilitate comprehensive and coordinated care for pregnant women with heart disease, addressing both their cardiac and obstetric needs.

6. Health education campaigns: Conducting targeted health education campaigns to raise awareness about the risks of heart disease during pregnancy and the importance of early detection and management. This can help reduce the stigma associated with seeking care and encourage women to access maternal health services.

7. Strengthening healthcare infrastructure: Investing in the development and improvement of healthcare infrastructure, particularly in underserved areas. This includes ensuring the availability of well-equipped facilities, trained healthcare professionals, and essential medications for managing heart disease during pregnancy.

It is important to note that these recommendations are general and may need to be tailored to the specific context and resources available in South Africa.
AI Innovations Description
Based on the information provided, the recommendation to improve access to maternal health in South Africa would be to develop innovative strategies for early detection, management, and treatment of antenatal heart disease. This can be achieved through the following steps:

1. Improve awareness and education: Develop educational programs targeting healthcare providers, pregnant women, and their families to increase awareness about the risks and symptoms of heart disease during pregnancy. This can help in early detection and timely intervention.

2. Strengthen antenatal care services: Enhance the capacity of healthcare facilities to provide comprehensive antenatal care, including routine screening for heart disease. This can be done by training healthcare providers, ensuring availability of necessary equipment and resources, and establishing referral systems for specialized care.

3. Implement standardized reporting criteria: Establish standardized reporting criteria for studies and research on antenatal heart disease in South Africa. This will help in collecting accurate and comparable data, which can be used to monitor the burden of the disease and evaluate the effectiveness of interventions.

4. Improve access to specialized care: Ensure that pregnant women with heart disease have access to specialized cardiac care, including timely diagnosis, appropriate management, and access to necessary medications. This may involve strengthening referral networks, establishing specialized clinics, and providing financial support for treatment.

5. Enhance collaboration and research: Encourage collaboration between healthcare providers, researchers, and policymakers to conduct further research on antenatal heart disease in South Africa. This can help in identifying gaps in knowledge, developing evidence-based guidelines, and implementing innovative interventions.

By implementing these recommendations, it is possible to improve access to maternal health and reduce the burden of antenatal heart disease in South Africa.
AI Innovations Methodology
Based on the provided information, here are some potential recommendations to improve access to maternal health in South Africa:

1. Increase awareness and education: Implement comprehensive public health campaigns to raise awareness about the importance of maternal health and the risks associated with heart disease during pregnancy. This can include targeted messaging through various media channels, community outreach programs, and educational materials for healthcare providers.

2. Strengthen healthcare infrastructure: Invest in improving healthcare facilities, particularly in areas with limited access to care. This can involve building or upgrading hospitals and clinics, ensuring availability of essential medical equipment and supplies, and training healthcare professionals to provide quality maternal care.

3. Enhance antenatal care services: Develop and implement standardized protocols for antenatal care that include routine screening for heart disease and other high-risk conditions. This can help identify women at risk early on and provide appropriate interventions and management.

4. Improve referral systems: Establish efficient referral systems between primary healthcare centers and specialized cardiac care facilities. This can ensure timely access to specialized care for pregnant women with heart disease, reducing complications and improving outcomes.

5. Strengthen collaboration between cardiology and obstetrics teams: Encourage collaboration and communication between cardiology and obstetrics teams to provide comprehensive care for pregnant women with heart disease. This can involve joint clinics, multidisciplinary meetings, and shared decision-making to optimize management and reduce risks.

To simulate the impact of these recommendations on improving access to maternal health, a methodology could include the following steps:

1. Define the baseline: Collect data on the current state of access to maternal health services, including the prevalence of heart disease in pregnant women, healthcare infrastructure, and maternal and perinatal outcomes.

2. Identify key indicators: Determine specific indicators that can measure the impact of the recommendations, such as the number of women screened for heart disease during antenatal care, the percentage of women referred to specialized care, and changes in maternal and perinatal mortality rates.

3. Develop a simulation model: Create a simulation model that incorporates the baseline data and the potential impact of the recommendations. This can involve using statistical methods, such as regression analysis or mathematical modeling, to estimate the potential changes in the identified indicators based on the implementation of the recommendations.

4. Validate the model: Validate the simulation model by comparing its predictions with real-world data from similar settings or previous interventions. This can help ensure the accuracy and reliability of the model.

5. Simulate different scenarios: Run the simulation model with different scenarios, varying the implementation strategies and intensity of the recommendations. This can help identify the most effective approaches to improve access to maternal health and estimate the potential impact of each scenario.

6. Analyze the results: Analyze the simulation results to assess the potential impact of the recommendations on improving access to maternal health. This can involve comparing the changes in the identified indicators between different scenarios and identifying the most promising strategies.

7. Refine and iterate: Based on the analysis, refine the recommendations and simulation model as needed. Iterate the simulation process to further optimize the strategies and estimate the potential long-term impact.

By following this methodology, policymakers and healthcare professionals can gain insights into the potential impact of different recommendations on improving access to maternal health and make informed decisions on resource allocation and implementation strategies.

Share this:
Facebook
Twitter
LinkedIn
WhatsApp
Email